Article
Dosage effect of a Phex mutation in a murine model of X-linked hypophosphatemia.
Calcified tissue international - 1 Aug 2013
Ichikawa Shoji, Gray Amie K, Bikorimana Emmanuel, Econs Michael J
Abstract excerpt
X-linked hypophosphatemia (XLH) is caused by mutations in the PHEX gene, which increase circulating levels of the phosphaturic hormone, fibroblast growth factor 23 (FGF23). Because XLH is a dominant disease, one mutant allele is sufficient for manifestation of the disease. However, the dosage effect of a PHEX mutation in XLH is not completely understood. To examine the effect of Phex genotypes, we compared serum...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
